News

Under Armour Revamps Restructuring Strategy and Outlook

Under Armour Revamps Restructuring Strategy and Outlook

Under Armour Updates Its Restructuring Plan for Future Growth

Under Armour, Inc. (NYSE: UAA) has recently shared important updates to its restructuring plan for fiscal year 2025. The company is focusing on optimizing its supply chain capabilities and enhancing overall business performance. This initiative is aimed at establishing a more effective operational framework as Under Armour looks towards a promising future.

Revised Financial Projections and Charge Estimates

Initially, Under Armour projected pre-tax restructuring and related charges to be between $70 million and $90 million. However, after a comprehensive review, the company now estimates these charges will be approximately $140 million to $160 million for both fiscal year 2025 and fiscal year 2026. This significant adjustment is largely due to the decision to close one of its major distribution centers by 2026.

Breakdown of Restructuring Charges

In terms of the expected charges, Under Armour anticipates up to $75 million in cash-related expenses. This includes around $30 million allocated for employee severance and benefits, along with $45 million associated with various transformational initiatives. Furthermore, the company projects $85 million in non-cash charges, which encompasses $7 million for employee severance and benefits and $78 million for impairments related to facilities and assets.

Striving for Greater Efficiency and Productivity

For the three months ending June 30, 2024, Under Armour recorded approximately $34 million in restructuring charges, which included $19 million in cash and $15 million in non-cash expenses. As the company continues to refine its strategies, it expects to achieve more than two-thirds of the restructured expenses by the conclusion of fiscal year 2025. This proactive strategy aims to bolster the company’s financial productivity and operational efficiency.

Leadership Insights on the Restructuring

In light of these updates, Under Armour's Chief Financial Officer, David Bergman, stressed the significance of recognizing opportunities for optimization. He remarked, "We continue to proactively identify opportunities to optimize our business to help create a better and stronger Under Armour. By enhancing our supply-chain network, we aim to evolve into a more efficient, uncomplicated, and adaptable company." His comments reflect the company's commitment to more streamlined operations.

Revised Expectations for Fiscal 2025

As part of the restructuring updates, Under Armour has also adjusted its fiscal 2025 outlook. The company now anticipates an operating loss between $220 million and $240 million, a notable change from earlier estimates. Adjusted operating income is projected to be between $140 million and $160 million, excluding the expected restructuring charges and litigation expenses.

Projected Loss Per Share

For fiscal 2025, Under Armour estimates a diluted loss per share in the range of $0.58 to $0.61. However, when accounting for restructuring impacts, the expected diluted earnings per share falls between $0.19 and $0.22. These revisions indicate a shift in the company’s financial outlook as it takes decisive steps forward.

Clarifying Non-GAAP Financial Adjustments

It’s essential to understand that Under Armour's financial announcements feature “adjusted” projections that exclude non-recurring charges from operations, such as litigation reserves and the effects of the restructuring plan. The management emphasizes that these non-GAAP financial measures are crucial for accurately assessing the company’s ongoing operations.

About Under Armour, Inc.

Based in Baltimore, Maryland, Under Armour, Inc. is a leading innovator in performance sports apparel, footwear, and accessories. With a strong commitment to enhancing human performance, the brand consistently develops innovative products designed to help athletes excel. For more insights about the company, further information is available through their official channels.

Frequently Asked Questions

What are the key changes in Under Armour's restructuring plan?

The key changes include an increase in anticipated restructuring charges to between $140 million and $160 million and a focus on optimizing supply chain efficiencies.

What is Under Armour's revised outlook for fiscal year 2025?

The revised outlook indicates an expected operating loss of $220 million to $240 million and adjusted operating income of $140 million to $160 million.

Who is the Chief Financial Officer of Under Armour?

The Chief Financial Officer of Under Armour is David Bergman, who highlighted the company's efforts toward optimization and productivity.

How much has Under Armour incurred in restructuring charges so far?

As of June 30, 2024, Under Armour has incurred approximately $34 million in restructuring charges.

What is Under Armour's stock ticker symbol?

Under Armour's stock ticker symbol is UAA, listed on the New York Stock Exchange.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 256

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 400

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 226

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 212

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 246

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 363

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

ARK Venture Fund Invests in Umoja's Innovative Cancer Research

Updated Category News Views 268

ARK Venture Fund Invests in Umoja's Innovative Cancer Research Cathie Wood's ARK Venture Fund has made a notable investment in Umoja's Series C funding round, marking a significant milestone for the biotech company. Umoja is dedicated to pioneering a transformative approach to cancer treatment, focusing on enhancing the patient's immune response through novel techniques....

Continue Reading
Hooker Furnishings Shows Solid Sequential Growth in Q2 Results

Updated Category News Views 41

Hooker Furnishings' Second Quarter Performance Hooker Furnishings Corporation (NASDAQ: HOFT), a well-established name in the home furnishings industry for more than a century, recently revealed its financial results for the second quarter of fiscal 2025. The company demonstrated resilience in the face of challenging market conditions. Sales Performance Insights Typically...

Continue Reading
Pulmonx Achieves Remarkable Financial Growth in 2024

Updated Category News Views 352

Pulmonx Achieves Record Financial Success in 2024 Pulmonx Corporation (Nasdaq: LUNG) has made significant strides in its financial performance, demonstrating a remarkable growth trajectory throughout 2024. This globally recognized leader in minimally invasive lung disease treatments reported promising results that highlight its strong business model and commitment to...

Continue Reading
Blue Hat Secures $4.3 Million Through Direct Share Offering

Updated Category News Views 129

Blue Hat Interactive Entertainment Technology Engages in Direct Share Offering Recently, Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) made headlines by announcing its entry into securities purchase agreements allowing it to raise an impressive $4.3 million. This initiative is aimed at bolstering the company's financial stability and enhancing its market...

Continue Reading
Celebrating Innovation: PTx Trimble's OutRun Secures Award

Updated Category News Views 469

PTx Trimble Triumphs with OutRun at the Davidson Prize OutRun Autonomous Grain Cart Now Available in the U.S. PTx Trimble, a collaboration between AGCO and Trimble that started in 2024, has made headlines by launching OutRun, a revolutionary autonomous grain cart that has just clinched the prestigious Davidson Prize at Commodity Classic 2025. This accolade recognizes...

Continue Reading